Hidradenitis Suppurativa

March 19, 2017 (San Diego, California) — Six weeks of compassionate treatment with intravenous (IV) ertapenem resulted in a dramatic improvement in patients with severe Hidradenitis Suppurativa (HS). The treatment "is hardly seen in the literature for this disease," reported Aude Nassif, MD, here at the American Academy of Dermatology 70th Annual Meeting. "It is the first time an antibiotic with no recognized anti-inflammatory activity has shown a real efficiency in HS, which raises the question of an infectious participation," said Dr. Nassif, who is from the Institute Pasteur in Paris, France. Despite the response, this therapy must still be considered an induction  Hidradenitis Suppurativa Treatment . "It needs complementary treatment with oral antibiotics and surgery. It can't prevent this, but it will help to reduce the number and size of excisions," she said. The study follows one recently published by her group (Dermatolog